John S Clemmer

13PUBLICATIONS
11CO-AUTHORS
AutoimmunityCardiology (incl. cardiovascular diseases)Molecular targetsRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 17, 2025
PHD2 Deletion in CD8+ T Cells Worsens TAC-Induced Cardiac Inflammation, Heart Failure, and Pulmonary Remodeling.

Lihong Pan, Xiaochen He, Rui Xu

|Aug 20, 2025
Predicting cardiac and renal responses to sacubitril/valsartan with a mathematical model of heart failure with preserved ejection fraction.

John S Clemmer, Michael E Hall, Jordan H Mallette

|Nov 13, 2023
Modeling the renoprotective mechanisms of SGLT2 inhibition in hypertensive chronic kidney disease.

John S Clemmer, Timothy E Yen, Yoshitsugu Obi

|Apr 12, 2023
Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction.

John S Clemmer, Taylor J Ward, Seth T Lirette

|Aug 19, 2022
Modeling the physiological roles of the heart and kidney in heart failure with preserved ejection fraction during baroreflex activation therapy.

John S Clemmer, W Andrew Pruett

|Nov 18, 2021
In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension.

John S Clemmer, W Andrew Pruett, Robert L Hester

Pageof 3